Back
Common Mechanism FAQ
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Relevant to AI safety discussions around biosecurity risks, as AI-assisted biological design increases the importance of screening mechanisms for dual-use biological sequences; represents a governance model for dangerous capability gatekeeping.
Metadata
Importance: 45/100documentationreference
Summary
This FAQ page from the International Biosecurity and Biosafety Initiative for Science (IBBIS) explains the Common Mechanism, a harmonized screening framework for nucleic acid synthesis providers to detect and prevent potentially dangerous biological sequences from being synthesized. It addresses questions about how the system works, who uses it, and why standardized biosecurity screening matters for preventing misuse of synthetic biology tools.
Key Points
- •The Common Mechanism provides a shared, standardized screening tool for DNA/RNA synthesis providers to check orders against databases of dangerous biological sequences.
- •It aims to close biosecurity gaps by harmonizing screening practices across the synthetic biology industry globally.
- •The system helps prevent bad actors from obtaining dangerous genetic material by flagging sequences of concern before synthesis occurs.
- •IBBIS developed this as a voluntary but coordinated industry standard to complement regulatory frameworks.
- •Addresses dual-use risks in synthetic biology where the same tools enabling beneficial research can potentially enable bioweapon creation.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 202618 KB
FAQs - IBBIS
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
About
People
Careers
News
Our Work
Commec Sequence Screening
Customer Screening
Global Synthesis Map
International Standards
Sequence Biosecurity Standards
Vulnerability Disclosure
Contact
FAQs
Common Mechanism for DNA Synthesis Screening
Last updated: July 2025
The Common Mechanism provides free, open-source, globally-available tools that help providers of synthetic DNA and RNA screen orders efficiently, securely, and in compliance with global biosecurity standards. These tools include:
commec, a software package designed as a global baseline for sequence screening
practical customer screening resources
support for other technical resources to strengthen synthesis screening
IBBIS’s tools are hosted in Switzerland, developed by an international consortium, and incorporate biosecurity standards from every continent. This page aims to answer some frequently asked questions about the Common Mechanism.
Other Resources
Webpage . Our Work: Common Mechanism. Available on ibbis.bio .
Code . commec: a free, open-source, globally available tool for DNA sequence screening . Available on Github .
Paper . Overcoming Challenges to Developing a Common Global Baseline for Nucleic Acid Synthesis Screening . Nicole Wheeler, Sarah R. Carter, Tessa Alexanian, Christopher Isaac, Piers Millett, Jaime Yassif. Applied Biosafety, April 2024. Available online ( archive</a >).
Whitepaper . Verifying Legitimacy: Findings from the Customer Screening Working Group, 2020-2023 . Tessa Alexanian, Sarah R. Carter. February 2024. Available online .
Frequently Asked Questions
GENERAL
What is the Common Mechanism’s main goal? The Common Mechanism aims to give every provider of synthetic DNA and RNA access to synthesis screening through free, open-source, globally-available tools.
The tools are designed to help providers screen orders efficiently, securely, and in compliance with global biosecurity standards. These tools include a software package designed as a global baseline for sequence screening; practical resources for customer screening; and supports technical resources to strengthen synthesis screening. The Common Mechanism tools are hosted in Switzerland, developed by an international consortium, and incorporate biosecurity standards from every continent.
Why is screening important? Industry leaders have recognized for nearly 20 years that some sequences, such as those that can reconstruct pathogen genomes, should only be sent to trusted customers. Doing this requires screening orders to recognize potentiall
... (truncated, 18 KB total)Resource ID:
9d09ae5ea1c89667 | Stable ID: sid_OzBAPiaDLE